Rallybio Corporation (RLYB) Expected Move

Expected move estimates the probable price range for a given period based on at-the-money options pricing. It reflects the market consensus for volatility over the selected timeframe.

Rallybio Corporation (RLYB) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $77.0M, listed on NASDAQ, employing roughly 15 people, carrying a beta of -1.10 to the broader market. Rallybio Corporation, a clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases. Led by Stephen Uden, public since 2021-07-29.

Expected move analysis estimates the probable price range implied by options pricing. No recent options activity for RLYB as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how expected move is reported and how to read the data →